Genovate Biotechnology Co (ROCO:4130) E10: NT$0.41 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4130 Genovate Biotechnology Co Ltd ROCO:4130
72 GF Score
Price NT$26.85
GF Value NT$22.20
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Genovate Biotechnology Co E10?

Genovate Biotechnology Co ROCO:4130 -4.62% 72 E10 is NT$0.41 as of Dec. 2025. GuruFocus rates ROCO:4130 with a GF Score™ of 72/100 and a GF Value™ of NT$22.20 (Modestly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Genovate Biotechnology Co's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$-0.039. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$0.41 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Genovate Biotechnology Co's average E10 Growth Rate was -6.80% per year. During the past 3 years, the average E10 Growth Rate was -6.40% per year. During the past 5 years, the average E10 Growth Rate was -7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Genovate Biotechnology Co was -6.00% per year. The lowest was -7.70% per year. And the median was -6.40% per year.

As of today (2026-07-14), Genovate Biotechnology Co's current stock price is NT$26.85. Genovate Biotechnology Co's E10 for the quarter that ended in Dec. 2025 was NT$0.41. Genovate Biotechnology Co's Shiller PE Ratio of today is 65.49.

During the past 13 years, the highest Shiller PE Ratio of Genovate Biotechnology Co was 84.39. The lowest was 34.77. And the median was 45.85.


Genovate Biotechnology Co  (ROCO:4130) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Genovate Biotechnology Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=26.85/0.41
=65.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Genovate Biotechnology Co was 84.39. The lowest was 34.77. And the median was 45.85.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Genovate Biotechnology Co E10 Related Terms


Genovate Biotechnology Co E10 Historical Data

* Premium members only.

The historical data trend for Genovate Biotechnology Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genovate Biotechnology Co E10 Chart

Genovate Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.50 0.49 0.44 0.41

Genovate Biotechnology Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.43 0.43 0.42 0.41

ROCO:4130 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Genovate Biotechnology Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genovate Biotechnology Co Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genovate Biotechnology Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Genovate Biotechnology Co's Shiller PE Ratio falls into.


ROCO:4130
72GF Score
Genovate Biotechnology Co Ltd ROCO:4130
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genovate Biotechnology Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genovate Biotechnology Co's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.039/324.0540*324.0540
=-0.039

Current CPI (Dec. 2025) = 324.0540.

Genovate Biotechnology Co Quarterly Data

per share eps CPI Adj_EPS
201603 0.203 238.132 0.276
201606 0.042 241.018 0.056
201609 0.068 241.428 0.091
201612 0.017 241.432 0.023
201703 0.118 243.801 0.157
201706 0.549 244.955 0.726
201709 0.253 246.819 0.332
201712 0.329 246.524 0.432
201803 0.194 249.554 0.252
201806 0.051 251.989 0.066
201809 0.239 252.439 0.307
201812 0.000 251.233 0.000
201903 0.195 254.202 0.249
201906 0.097 256.143 0.123
201909 0.036 256.759 0.045
201912 -0.036 256.974 -0.045
202003 0.163 258.115 0.205
202006 0.117 257.797 0.147
202009 0.120 260.280 0.149
202012 -0.074 260.474 -0.092
202103 0.074 264.877 0.091
202106 -0.028 271.696 -0.033
202109 -0.065 274.310 -0.077
202112 0.022 278.802 0.026
202203 -0.083 287.504 -0.094
202206 0.028 296.311 0.031
202209 0.065 296.808 0.071
202212 -0.111 296.797 -0.121
202303 0.111 301.836 0.119
202306 0.111 305.109 0.118
202309 0.142 307.789 0.150
202312 -0.123 306.746 -0.130
202403 0.142 312.332 0.147
202406 0.066 314.175 0.068
202409 0.048 315.301 0.049
202412 -0.039 315.605 -0.040
202503 0.085 319.799 0.086
202506 0.066 322.561 0.066
202509 -0.010 324.800 -0.010
202512 -0.039 324.054 -0.039

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$0.41 mean?
Genovate Biotechnology Co (ROCO:4130) has a E10 of NT$0.41 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Genovate Biotechnology Co and its competitors.
Is Genovate Biotechnology Co's E10 too high?
Genovate Biotechnology Co's current E10 is NT$0.41. Overall, Genovate Biotechnology Co has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Genovate Biotechnology Co's E10 compare to VRTX and REGN?
Genovate Biotechnology Co's E10 of NT$0.41 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Genovate Biotechnology Co and its competitors. Genovate Biotechnology Co's current E10 is NT$0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genovate Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Genovate Biotechnology Co (ROCO:4130) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$22.20, compared to a current price of NT$26.85 — trading 20.9% above its estimated fair value. The current E10 is NT$0.41. Genovate Biotechnology Co's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Genovate Biotechnology Co (ROCO:4130), the current E10 is NT$0.41 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genovate Biotechnology Co (ROCO:4130) Overvalued in 2026?

Based on GuruFocus' analysis, Genovate Biotechnology Co stock appears to be overvalued. The current stock price of NT$26.85 is trading 20.9% above its estimated GF Value™ of NT$22.20. GuruFocus considers Genovate Biotechnology Co to be Modestly Overvalued.

Key valuation signals for ROCO:4130:

  • E10: NT$0.41
  • GF Value™: NT$22.20 vs. price of NT$26.85 (20.9% above fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4130 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genovate Biotechnology Co Business Description

Address No.1, First Industrial Road, Hsin-Chu Expanded Park, Hukou Township, Guangdong Province, Hsin-Chu county, Hsin-Chu, TWN, 303036
Genovate Biotechnology Co Ltd develops, produces, manufactures, and sales of medicines for the prevention and treatment of diseases caused by viruses and bacteria, and medicines for the treatment of cardiovascular, gastrointestinal, cancer, and autoimmune diseases, etc. The company is also engaged in the sales of medicines for the prevention and treatment of diseases caused by viruses and bacteria, and medicines for the treatment of cardiovascular, gastrointestinal, cancer, and autoimmune diseases etc.
72GF Score

Get the complete analysis for ROCO:4130

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$26.85
Price
NT$22.20
GF Value